Alcami Corp. announced it has acquired TriPharm Services and its sterile fill-finish manufacturing center near Research Triangle Park, according to a news release.

TriPharm's facility, which is expected to be fully operational in the second half of 2020, will add to Alcami's existing sterile fill-finish business to meet growing industry demand, stated the release.

The terms of the deal were not disclosed, Jonathan Granger, Alcami’s corporate communications manager, said in an email Monday.

Durham-based Alcami, a provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, has about 430 employees in Wilmington and about 900 employees companywide, Granger said.

“In conjunction with this acquisition, funds affiliated with Madison Dearborn Partners, LLC ("MDP"), Alcami's existing majority owner, made an additional equity investment to fund Alcami's growth plan and the former majority owner of TriPharm, Ampersand Capital Partners, rolled a portion of its TriPharm ownership interest into an ownership interest in Alcami,” stated the release.

The acquisition of the facility follows Alcami’s recently announced $17 million expansion of its sterile fill-finish facility in Charleston, South Carolina.

“Our combination with TriPharm is an important next step in the execution of Alcami's strategy to focus investments across our network to better serve rapidly growing specialized market segments," said Alcami interim CEO George Van Kula, in the release. "TriPharm expands our existing capabilities and provides additional equipment lines that will allow us to better serve the fast-developing biologics market segment.”